Immunity Supplement EU Organic Echinacea Purpurea Extract Powder

Name: Immunity Supplement EU Organic Echinacea Purpurea Extract Powder
Brand: Xi an Sost Biotech Co., Ltd.
SKU: 1911634095

Shaanxi, ChinaXi an Sost Biotech Co., Ltd.

US$7.50-60.50

2 kg

Sample price:US$7.50/kg.Request sample

Product profile

Customization

Available

Certification

RoHS, USDA Organic/EU Organic/ISO/Kosher/Halal/FDA

Assay Method

HPLC

Model NO.

Organic Echinacea Purpurea Extract Powder

Application Form

Powder

Application

Health Care Products

State

Powder

Extract Source

plant

Powder

Yes

Customized

Suitable for

Adult

Purity

>99%

State

Whole Herb

Product Name

Organic Echinacea Purpurea Extract Powder

Appearance

Brown Yellow Powder

sample

Free Sample

COA

Available

Certificate

EU Organic/ISO/Kosher/Halal

Stock

In Stock

Shelf Life

24 Months

Model Number

Echinacea Extract

Active Ingredient

Polyphenols, Chicoric Acid

Extraction Type

Solvent Extraction

Test method

HPLC/UV

Type

Echinacea Purpurea Extract

Grade

Pharmaceutical/Food Grade

Latin Name

Echinacea Purpurea

Transport Package

Aluminum Foil Bag/Drum

Specification

4%-7% Polyphenols, 1%-4% Chicoric Acid

Trademark

Sost Biotech

Origin

China

Production Capacity

Metric Tons Per Month

Company profile

Xi an Sost Biotech Co., Ltd.

Shaanxi, China

CertifiedBusiness Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2012-11-01 CertifiedNearest Port: Shanghai PortAverage Response Time: ≤2.74h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryXi'an Sost Biotech Co., Ltd. is identified as a China-based manufacturer and trading company focused on herbal extracts, Chinese medicine raw materials, cosmetic ingredients, healthcare ingredients, food additives, and dietary supplement ingredients. Evidence indicates established production, R&D, sales, purchasing, and quality-control functions, with stated GMP-oriented operations, ISO 9001:2015 certification, multiple production bases, and broad export coverage. However, the records contain conflicting production information: one slice reports three production bases and eight lines, while another reports a 2,990 m² plant and two production lines. The supplier states that it provides pre- and after-sales service and accepts several trade and payment terms, but detailed service performance, customization results, customer references, and financial strength are not sufficiently documented. Monetary figures are omitted.

Supplier typeThe supplier is explicitly classified as a manufacturer and limited company, while another record identifies its business nature as a trading company. Its stated activities include R&D, production, sales, and service of herbal extracts and natural raw materials, so it appears to combine manufacturing and trading functions.

CertificationsThe supplier reports ISO 9001:2015 certification and states that production follows national GMP standards, with GMP-standard factories and 100,000-level clean workshops. ISO certification is explicit; the GMP statements are operational claims rather than a separately named certificate.

After-Sales capabilityThe company explicitly emphasizes before-sales and after-sales service, states that it continuously improves service, and describes service as part of its business operations. However, no evidence gives measurable after-sales performance, service staffing, response times, or documented customer outcomes.

R&D capabilityThe supplier reports an R&D department, research and development of high-purity natural products, biological engineering and natural extraction technology, and an innovation-oriented approach. Nevertheless, only two years of R&D engineer experience are reported, and there is no evidence of patents, new-product records, or quantified R&D achievements.

Production capacityProduction capability is supported by a stated manufacturing plant, natural-extract production activities, GMP-oriented facilities, clean workshops, and product lines covering food, healthcare, cosmetics, and pharmaceutical intermediates. The data are inconsistent: one record states three production bases and eight lines, while another reports a 2,990 m² plant and two lines; quality-control staffing is also reported as fewer than five employees.